11β-hydroxylase deficiency epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
The prevalence of | The [[prevalence]] of 11β-hydroxylase deficiency is approximately 1 per 100,000 individuals the United States. 11β-hydroxylase deficiency affects males and females equally. This disease usually affects individuals of the Jewish race. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
* | * Worldwide, the prevalence of 11β-hydroxylase deficiency is 20 per 100,000 persons.<ref name="pmid1554023">{{cite journal| author=Rösler A, Leiberman E, Cohen T| title=High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. | journal=Am J Med Genet | year= 1992 | volume= 42 | issue= 6 | pages= 827-34 | pmid=1554023 | doi=10.1002/ajmg.1320420617 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1554023 }} </ref> | ||
===Incidence=== | ===Incidence=== | ||
* 11β-hydroxylase deficiency accounts for 5 percent of all cases of congenital adrenal hyperplasia. It is estimated that | * 11β-hydroxylase deficiency accounts for 5 percent of all cases of [[congenital adrenal hyperplasia]] and it is considered the second most frequent variant after [[21-hydroxylase deficiency]]. It is estimated that 11-beta-hydroxylase deficiency occurs in 1 in 100,000 to 200,000 newborns. | ||
* 11β-hydroxylase deficiency is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns.<ref name="pmid1554023">{{cite journal| author=Rösler A, Leiberman E, Cohen T| title=High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. | journal=Am J Med Genet | year= 1992 | volume= 42 | issue= 6 | pages= 827-34 | pmid=1554023 | doi=10.1002/ajmg.1320420617 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1554023 }} </ref><ref name="pmid7988480">{{cite journal |vauthors=White PC, Curnow KM, Pascoe L |title=Disorders of steroid 11 beta-hydroxylase isozymes |journal=Endocr. Rev. |volume=15 |issue=4 |pages=421–38 |year=1994 |pmid=7988480 |doi=10.1210/edrv-15-4-421 |url=}}</ref> | * 11β-hydroxylase deficiency is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns.<ref name="pmid1554023">{{cite journal| author=Rösler A, Leiberman E, Cohen T| title=High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. | journal=Am J Med Genet | year= 1992 | volume= 42 | issue= 6 | pages= 827-34 | pmid=1554023 | doi=10.1002/ajmg.1320420617 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1554023 }} </ref><ref name="pmid7988480">{{cite journal |vauthors=White PC, Curnow KM, Pascoe L |title=Disorders of steroid 11 beta-hydroxylase isozymes |journal=Endocr. Rev. |volume=15 |issue=4 |pages=421–38 |year=1994 |pmid=7988480 |doi=10.1210/edrv-15-4-421 |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
* | * 11β-hydroxylase deficiency affects males and females equally. | ||
===Race=== | ===Race=== | ||
* | * 11β-hydroxylase deficiency usually affects individuals of the Jewish race. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 13:59, 3 August 2017
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency epidemiology and demographics |
|
FDA on 11β-hydroxylase deficiency epidemiology and demographics |
|
CDC on 11β-hydroxylase deficiency epidemiology and demographics |
|
11β-hydroxylase deficiency epidemiology and demographics in the news |
|
Blogs on 11β-hydroxylase deficiency epidemiology and demographics |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The prevalence of 11β-hydroxylase deficiency is approximately 1 per 100,000 individuals the United States. 11β-hydroxylase deficiency affects males and females equally. This disease usually affects individuals of the Jewish race.
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of 11β-hydroxylase deficiency is 20 per 100,000 persons.[1]
Incidence
- 11β-hydroxylase deficiency accounts for 5 percent of all cases of congenital adrenal hyperplasia and it is considered the second most frequent variant after 21-hydroxylase deficiency. It is estimated that 11-beta-hydroxylase deficiency occurs in 1 in 100,000 to 200,000 newborns.
- 11β-hydroxylase deficiency is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns.[1][2]
Gender
- 11β-hydroxylase deficiency affects males and females equally.
Race
- 11β-hydroxylase deficiency usually affects individuals of the Jewish race.
References
- ↑ 1.0 1.1 Rösler A, Leiberman E, Cohen T (1992). "High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco". Am J Med Genet. 42 (6): 827–34. doi:10.1002/ajmg.1320420617. PMID 1554023.
- ↑ White PC, Curnow KM, Pascoe L (1994). "Disorders of steroid 11 beta-hydroxylase isozymes". Endocr. Rev. 15 (4): 421–38. doi:10.1210/edrv-15-4-421. PMID 7988480.